ribavirin has been researched along with African Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, J; Forns, X; García-López, M; Lens, S; Navasa, M; Pérez-Del-Pulgar, S; Sastre, L | 1 |
| Dolničar, MB; Jazbec, J; Kitanovski, L; Kopriva, S; Pokorn, M; Rajić, V; Stefanović, M | 1 |
| Ben-Barak, A; Kassis, I; Shachor-Meyouhas, Y | 1 |
3 other study(ies) available for ribavirin and African Lymphoma
| Article | Year |
|---|---|
The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Burkitt Lymphoma; Common Variable Immunodeficiency; Drug Therapy, Combination; Fatal Outcome; Focal Nodular Hyperplasia; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Kidney Transplantation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Ribavirin; RNA, Viral; Sofosbuvir | 2020 |
Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Burkitt Lymphoma; Child, Preschool; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Metapneumovirus; Paramyxoviridae Infections; Pneumonia, Viral; Ribavirin; Treatment Outcome | 2013 |
Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immune compromised child.
Topics: Antiviral Agents; Burkitt Lymphoma; Child; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Male; Metapneumovirus; Paramyxoviridae Infections; Pneumonia, Viral; Ribavirin | 2011 |